Healthcare Resource Utilization and Associated Costs in Patients With Advanced Melanoma Receiving First-Line Ipilimumab

Journal of Cancer Therapy
doi 10.4236/jct.2015.610091
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Scientific Research Publishing, Inc,